http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3476831-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56b29cff990807d0701e74876774dffc
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
filingDate 2017-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4483cf7c2dabdaefccb182f5d11aaa5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c413207b499353083a1948da50c5efe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36f0671b31293b5ea8ebb2daf654ca10
publicationDate 2019-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3476831-A1
titleOfInvention Crystal form of 9-aminomethyl substituted tetracycline compounds and preparation method therefor
abstract The present invention belongs to the field of pharmaceutical technology, and crystal forms of a 9-aminomethyl substituted tetracycline compound and a process for preparing the same. More specifically, the present invention relates to crystal forms of the compound represented by formula (1), a process for preparing crystal forms of the compound represented by formula (1) and use of said crystal forms in manufacture of medicament for treating and/or preventing an infection disease caused by tetracycline-sensitive bacteria and/or tetracycline-resistant bacteria.
priorityDate 2016-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID138584002
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54686904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID130221963
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID384805251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66597886
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID239645404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226476914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226476913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID344166149
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54685767
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71243332

Total number of triples: 42.